公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2016 | Lenalidomide as second-line therapy for advanced hepatocellular carcinoma (HCC): biomarker exploration | Shao, Y-Y.; Chen, B-B.; Lin, Z-Z.; Hsu, C-H.; Wang, M-J.; Cheng, A-L.; Hsu, C.; 邵幼雲; 鄭安理; 陳邦斌; 徐志宏 | Annals of Oncology | 0 | 1 | |
1987 | Lineage Specific Classification of Adult Acute Lymphoblastic Leukemia:Analysis of 30 Cases | Cheng, Ann-Lii; Chen, Yee-Chun; 鄭安理 | Journal of the Formosan Medical Association | | | |
2015 | LONG-TERM OUTCOME OF CHEMOTHERAPY-INDUCED HBV REACTIVATION IN LYMPHOMA PATIENTS WITH RESOLVED HBV INFECTION | Yang, H. -C.; Tsou, H. -H.; Chuang, M. -H.; Chen, C. -L.; Liu, T. -W.; Chen, P. -J.; Cheng, A. -L.; Hsu, C.; 鄭安理; 陳培哲; 陳祈玲 | J. Hepatol. | | | |
2005 | Long-Term Results of Anti–Helicobacter Pylori Therapy in Early-Stage Gastric High-Grade Transformed Malt Lymphoma | CHENG, ANN-LII; WHANG-PENG, JACQUELINE; SU, IH-JEN; JAN, CHANG-MING; SHEU, BOR-SHYANG; KUO, SUNG-HSIN; WANG, HSIU-PO; CHEN, GRAN-HUM; TAI, JOHN JEN; LIN, JAW-TOWN; CHEN, LI-TZONG; 鄭安理 | JOURNAL OF THE NATIONAL CANCER INSTITUTE | | | |
2012 | LOW FREQUENCIES OF BRAF AND B-CATENIN (CTNNB1) MUTATIONS IN ADVANCED HEPATOCELLULAR CARCINOMA | Lu, L. -C.; Shao, Y. -Y.; Hsieh, M. -S.; Huang, C. -C.; Cheng, A. -L.; Hsu, C. -H.; 邵幼雲; 鄭安理; 徐志宏; 謝明書 | Ann. Oncol. | | | |
1998 | Megestrol Acetate Antagonizes Cisplatin Cytotoxicity | PU, YEONG-SHIAU; CHENG, ANN-LII; CHEN, JUN; GUAN, JING-YI; LIU, SHIO-HUEI; LAI, MING-KUEN; HSIEH, CHANG-YAO; 鄭安理 | ANTICANCER RESEARCH | | | |
1991 | Menadione-Induced DNA Damage in a Human Tumor Cell Line | Sun, T. P.; Chang, J. Y.; Wang, C. C.; Cheng, Ann-Lii; Nutter, L. M.; Ngo, E. O.; Chi, K. H.; 鄭安理 | Biochemical Pharmacology | | | |
1991 | Menadione-Spectrum of Anticancer Activity and Effects on Nucleotide Metabolism | Cheng, Ann-Lii; Hsieh, R. K.; Ngo, E. O.; Nutter, L. M.; 鄭安理 | Biochemical Pharmacology | | | |
1991 | Menadione: Spectrum of Anticancer Activity and Effects on Nucleotide Metabolism in Human Neoplastic Cell Lines | NUTTER LOUISE M.; CHENG, ANN-LII; HUNG, HSIAO-LING; HSIEH, RUEY-KUN; NGO EMILY O; LIU, TSANG-WU; 鄭安理 | BIOCHEMICAL PHARMACOLOGY | | | |
1990 | Metabolic Effects of Suramin(S) on Human Prostatic Cancer Cells | Rago, R.; Mitchen, J.; Cheng, Ann-Lii; 鄭安理 | Annual Meeting of the American Association for Cancer Research. Proceedings | | | |
1994 | Modulation of Retinoic Acid Receptor α, Growth Factors, and Protooncogenes in Retinoic Acid-Induced Apoptosis of Ki-1 Lymphoma Cell Line | Cheng, Ann-Lii; Chang, I. C.; Su, I. J.; Lay, A. D.; 鄭安理 | International Journal of Oncology | | | |
2014 | Nuclear expression of BCL10 has a role in the regulation of cell growth and progression of pancreatic cancer through the activation of NF-kappa B-related signaling | Kuo, Sung-Hsin; Yang, Shih-Hung; Yeh, Kun-Huei; Yeh, Pei-Yen; Tien, Yu-Wen; Lee, Hsiao-Wei; Chen, Li-Tzong; Cheng, Ann-Lii; 鄭安理 | Cancer Res. | 0 | 0 | |
2001 | Nuclear Extracellular Signal-Regulated Kinase 2 Phosphorylates P53 at Thr 55 in Response to Doxorubicin | CHENG, ANN-LII; 鄭安理 | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | | | |
2011 | Optimization of Culture Condition for ACEI and GABA Production by Lactic Acid Bacteria | Tung, YT; Ou, Da-Liang; TZU-MING PAN ; Tung, Yi-Ting; Chang, Chun-Jung; Lee, BH; Lee, Bao-Hong; Liu, CF; Jeng, Yung-Ming; Liu, Chin-Feng; Lin, Yi-Jang; Pan, Tzu-Ming ; Pan, TM.; Lin, Zhong-Zhe; Gandhi, Anita K.; Liao, Sheng-Chieh; Huang, Zi-Ming; Hsu, Chiun; Cheng, Ann-Lii; 鄭永銘; 張純榮; 林宗哲; 鄭安理; 許駿; 歐大諒 | Journal of Food Science | 32 | 26 | |
2002 | P53 Overexpression Predicts Poor Chemosensitivity to High-Dose 5- Fluorouracil Plus Leucovorin Chemotherapy for Stage Iv Colorectal Cancers after Palliative Bowel Resection | LIANG, JIN-TUNG; 鄭安理 | INTERNATIONAL JOURNAL OF CANCER | | | |
2016 | Pembrolizumab in patients with previously treated advanced hepatocellular carcinoma: Phase 2 KEYNOTE-224 study | Zhu, A.; Knox, J.; Kudo, M.; Chan, S.; Finn, R.; Siegel, A.; Ma, J.; Watson, P. A.; Cheng, A-L.; 鄭安理 | Annals of Oncology | 0 | 2 | |
1992 | Peripheral T-Cell Lymphoma and Adult T-Cell Lymphoma/Leukemia | Cheng, Ann-Lii; 鄭安理 | Current Therapy for Hematology/Oncology | | | |
2006 | Phase I-Ii Trial of Weekly Gemcitabine Plus High-Dose 5-Fluorouracil and Leucovorin in Advanced Pancreatic Cancer | CHENG, ANN-LII; HSU, CHIUN; HSU, CHIH-HUNG; 鄭安理 | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | | | |
2005 | A Phase Ii Study in Taiwan with Navelbine(Nvb) Oral in Combinatino with Cisplatin (C) in Advanced Non-Small Cell Lung Cancer (Nsclc) Patients | YU, CHONG-JEN; YANG, CHIH-HSIN; CHENG, ANN-LII; YANG, PAN-CHYR; 鄭安理; 楊泮池 | LUNG CANCER | | | |
2009 | A Phase Ii Study of Gemcitabine-Based Chemoradiotherapy (Ccrt) after Triplet Induction Chemotherapy (Ict) for Locally Advanced Pancreatic Cancer (Lapc): A Taiwan Cooperative Oncology Group (Tcog) Study | CHENG, ANN-LII; CHEN, LI-TZONG; 鄭安理 | JOURNAL OF CLINICAL ONCOLOGY | | | |